MedTrace Logo

Behavioral Safety and Fentanyl Education: BSAFE

NCT07219082 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-04-16

No results posted yet for this study

Summary

BSAFE is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among people who use stimulants who may have unintentional fentanyl use (UFU). It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. This study will test the efficacy of BSAFE vs attention-control.

Conditions

  • Drug Overdose
  • Drug Overdose Accidental

Interventions

BEHAVIORAL

BSAFE Intervention

The intervention will include counseling sessions, reminder safety text messages, and linkage to care.

BEHAVIORAL

Attention control

Attention control (videos)

Sponsors & Collaborators

  • San Francisco Department of Public Health

    lead OTHER_GOV

Principal Investigators

  • Phillip O Coffin, MD, MIA · San Francisco Department of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2030-01-15
Completion
2030-01-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07219082 on ClinicalTrials.gov